» Articles » PMID: 26432894

Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis

Abstract

In the intestinal tract, IL-22 activates STAT3 to promote intestinal epithelial cell (IEC) homeostasis and tissue healing. The mechanism has remained obscure, but we demonstrate that IL-22 acts via tyrosine kinase 2 (Tyk2), a member of the Jak family. Using a mouse model for colitis, we show that Tyk2 deficiency is associated with an altered composition of the gut microbiota and exacerbates inflammatory bowel disease. Colitic Tyk2(-/-) mice have less p-STAT3 in colon tissue and their IECs proliferate less efficiently. Tyk2-deficient primary IECs show reduced p-STAT3 in response to IL-22 stimulation, and expression of IL-22-STAT3 target genes is reduced in IECs from healthy and colitic Tyk2(-/-) mice. Experiments with conditional Tyk2(-/-) mice reveal that IEC-specific depletion of Tyk2 aggravates colitis. Disease symptoms can be alleviated by administering high doses of rIL-22-Fc, indicating that Tyk2 deficiency can be rescued via the IL-22 receptor complex. The pivotal function of Tyk2 in IL-22-dependent colitis was confirmed in Citrobacter rodentium-induced disease. Thus, Tyk2 protects against acute colitis in part by amplifying inflammation-induced epithelial IL-22 signaling to STAT3.

Citing Articles

TYK2 Protein Expression and Its Potential as a Tissue-Based Biomarker for the Diagnosis of Colorectal Cancer.

Zadka L, Ustaszewski A, Glatzel-Plucinska N, Rusak A, Laczmanska I, Ratajczak-Wielgomas K Cancers (Basel). 2024; 16(21).

PMID: 39518103 PMC: 11545102. DOI: 10.3390/cancers16213665.


Saffron reduces the liver fibrosis in mice by inhibiting the JAK/STAT3 pathway.

Huang L, Han Y, Wang Z, Qiu Q, Yue S, Zhou Q Acta Cir Bras. 2023; 38:e385823.

PMID: 38055395 PMC: 10691186. DOI: 10.1590/acb385823.


Epithelial dysfunction is prevented by IL-22 treatment in a Citrobacter rodentium-induced colitis model that shares similarities with inflammatory bowel disease.

Zhu Q, Korenfeld D, Suarez-Fueyo A, Graham S, Jin L, Punit S Mucosal Immunol. 2022; 15(6):1338-1349.

PMID: 36372810 DOI: 10.1038/s41385-022-00577-w.


Tyk2 is a tumor suppressor in colorectal cancer.

Moritsch S, Modl B, Scharf I, Janker L, Zwolanek D, Timelthaler G Oncoimmunology. 2022; 11(1):2127271.

PMID: 36185806 PMC: 9519006. DOI: 10.1080/2162402X.2022.2127271.


Cranberry polyphenols and agave agavins impact gut immune response and microbiota composition while improving gut barrier function, inflammation, and glucose metabolism in mice fed an obesogenic diet.

Medina-Larque A, Rodriguez-Daza M, Roquim M, Dudonne S, Pilon G, Levy E Front Immunol. 2022; 13:871080.

PMID: 36052065 PMC: 9424773. DOI: 10.3389/fimmu.2022.871080.


References
1.
Lian L, Lau T, Lee V, Lee W, Hilmi I, Goh K . Lack of association between TYK2 and STAT3 genes and Crohn's disease in the Malaysian population. Genet Mol Res. 2013; 12(1):167-74. DOI: 10.4238/2013.January.24.9. View

2.
Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Flavell R . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29(6):947-57. PMC: 3269819. DOI: 10.1016/j.immuni.2008.11.003. View

3.
Strobl B, Stoiber D, Sexl V, Mueller M . Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity. Front Biosci (Landmark Ed). 2011; 16(9):3214-32. DOI: 10.2741/3908. View

4.
Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, Kolbe T . Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol. 2005; 175(6):4000-8. DOI: 10.4049/jimmunol.175.6.4000. View

5.
Rauch I, Rosebrock F, Hainzl E, Heider S, Majoros A, Wienerroither S . Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol. 2015; 35(13):2332-43. PMC: 4456449. DOI: 10.1128/MCB.01498-14. View